Ian Mortimer
Chief Executive Officer at XENON PHARMACEUTICALS INC.
Net worth: 2 M $ as of 2024-04-29
Ian Mortimer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| XENON PHARMACEUTICALS INC. | Director/Board Member | 2021-06-02 | - |
| Chief Executive Officer | 2021-06-02 | - | |
| President | 2018-03-11 | - | |
| Chief Operating Officer | 2015-03-11 | 2018-03-11 | |
| Director of Finance/CFO | 2013-10-20 | 2021-06-02 | |
| Investor Relations Contact | 2013-10-20 | - | |
| Corporate Secretary | 2015-05-31 | 2021-06-02 | |
| PERIMETER MEDICAL IMAGING AI, INC. | Director/Board Member | 2020-07-02 | - |
Xenon Pharmaceuticals USA, Inc.
 Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Director/Board Member | - | - |
| President | - | - | |
| Treasurer | - | - |
Career history of Ian Mortimer
Former positions of Ian Mortimer
| Companies | Position | Start | End |
|---|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Director of Finance/CFO | 2003-12-31 | 2013-09-30 |
Perimeter Medical Imaging, Inc.
 Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada. | Director/Board Member | 2020-07-02 | - |
| APPILI THERAPEUTICS INC. | Director/Board Member | 2017-11-27 | 2020-01-26 |
| Chairman | 2020-01-26 | - | |
| Independent Dir/Board Member | 2017-11-27 | - |
Training of Ian Mortimer
| University of British Columbia | Undergraduate Degree |
| Queen's University | Masters Business Admin |
Statistics
International
| Canada | 7 |
| United States | 3 |
Operational
| Director/Board Member | 5 |
| Director of Finance/CFO | 2 |
| President | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| APPILI THERAPEUTICS INC. | Health Technology |
| PERIMETER MEDICAL IMAGING AI, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Xenon Pharmaceuticals USA, Inc.
Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Health Technology |
Perimeter Medical Imaging, Inc.
Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Ian Mortimer
- Experience
